JP2020039342A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020039342A5 JP2020039342A5 JP2019195276A JP2019195276A JP2020039342A5 JP 2020039342 A5 JP2020039342 A5 JP 2020039342A5 JP 2019195276 A JP2019195276 A JP 2019195276A JP 2019195276 A JP2019195276 A JP 2019195276A JP 2020039342 A5 JP2020039342 A5 JP 2020039342A5
- Authority
- JP
- Japan
- Prior art keywords
- cfh
- medical device
- functional sequence
- recombinant protein
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000016550 Complement Factor H Human genes 0.000 claims 20
- 108010053085 Complement Factor H Proteins 0.000 claims 20
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 claims 9
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 claims 9
- 102000004169 proteins and genes Human genes 0.000 claims 7
- 108090000623 proteins and genes Proteins 0.000 claims 7
- 239000012634 fragment Substances 0.000 claims 3
- 230000001939 inductive effect Effects 0.000 claims 3
- 150000001413 amino acids Chemical class 0.000 claims 2
- 230000000295 complement effect Effects 0.000 claims 2
- 102000034356 gene-regulatory proteins Human genes 0.000 claims 2
- 108091006104 gene-regulatory proteins Proteins 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 239000003094 microcapsule Substances 0.000 claims 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 239000011324 bead Substances 0.000 claims 1
- 210000001124 body fluid Anatomy 0.000 claims 1
- 239000010839 body fluid Substances 0.000 claims 1
- 239000007943 implant Substances 0.000 claims 1
- 230000000399 orthopedic effect Effects 0.000 claims 1
- 230000000717 retained effect Effects 0.000 claims 1
- 230000002792 vascular Effects 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021195598A JP7320585B2 (ja) | 2013-10-14 | 2021-12-01 | 診断的および治療的使用を有するタンパク質 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1318170.6 | 2013-10-14 | ||
| GBGB1318170.6A GB201318170D0 (en) | 2013-10-14 | 2013-10-14 | Proteins with Diagnostic and Therapeutic Uses |
| JP2016522745A JP6691042B2 (ja) | 2013-10-14 | 2014-10-13 | 診断的および治療的使用を有するタンパク質 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016522745A Division JP6691042B2 (ja) | 2013-10-14 | 2014-10-13 | 診断的および治療的使用を有するタンパク質 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021195598A Division JP7320585B2 (ja) | 2013-10-14 | 2021-12-01 | 診断的および治療的使用を有するタンパク質 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020039342A JP2020039342A (ja) | 2020-03-19 |
| JP2020039342A5 true JP2020039342A5 (enExample) | 2020-04-30 |
| JP6987825B2 JP6987825B2 (ja) | 2022-01-05 |
Family
ID=49680023
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016522745A Active JP6691042B2 (ja) | 2013-10-14 | 2014-10-13 | 診断的および治療的使用を有するタンパク質 |
| JP2019195276A Active JP6987825B2 (ja) | 2013-10-14 | 2019-10-28 | 診断的および治療的使用を有するタンパク質 |
| JP2021195598A Active JP7320585B2 (ja) | 2013-10-14 | 2021-12-01 | 診断的および治療的使用を有するタンパク質 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016522745A Active JP6691042B2 (ja) | 2013-10-14 | 2014-10-13 | 診断的および治療的使用を有するタンパク質 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021195598A Active JP7320585B2 (ja) | 2013-10-14 | 2021-12-01 | 診断的および治療的使用を有するタンパク質 |
Country Status (11)
| Country | Link |
|---|---|
| US (4) | US10035827B2 (enExample) |
| EP (2) | EP3057979B1 (enExample) |
| JP (3) | JP6691042B2 (enExample) |
| CN (3) | CN114028538A (enExample) |
| AU (3) | AU2014335925B2 (enExample) |
| BR (1) | BR112016008055A2 (enExample) |
| CA (1) | CA2925663A1 (enExample) |
| DK (1) | DK3057979T3 (enExample) |
| ES (2) | ES3037618T3 (enExample) |
| GB (1) | GB201318170D0 (enExample) |
| WO (1) | WO2015055991A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017075189A1 (en) * | 2015-10-27 | 2017-05-04 | University Of Massachusetts | Factor h-fc immunotherapy |
| WO2017114401A1 (zh) * | 2015-12-31 | 2017-07-06 | 江苏匡亚生物医药科技有限公司 | 具有补体调节活性的重组补体因子h-免疫球蛋白融合蛋白及其制备方法与应用 |
| GB201800620D0 (en) | 2018-01-15 | 2018-02-28 | Univ Manchester | C3b Binding Polypeptide |
| KR20220057530A (ko) * | 2019-07-17 | 2022-05-09 | 제미니 테라퓨틱스 서브, 인코포레이티드 | 인자 h 강화 항체 및 이의 용도 |
| IL299048A (en) | 2020-06-14 | 2023-02-01 | Vertex Pharma | Variants of complement factor - 1 fusion structures and preparations containing them and their uses |
| EP4001301A1 (en) * | 2020-11-13 | 2022-05-25 | Navigo Proteins Gmbh | Binding protein for complement factor h (cfh) |
| GB202102931D0 (en) | 2021-03-02 | 2021-04-14 | Invizius Ltd | Peritoneal fluid composition |
| GB202202728D0 (en) | 2022-02-28 | 2022-04-13 | Invizius Ltd | Peritoneal fluid composition |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5168062A (en) | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
| US4980286A (en) | 1985-07-05 | 1990-12-25 | Whitehead Institute For Biomedical Research | In vivo introduction and expression of foreign genetic material in epithelial cells |
| CH680045A5 (enExample) * | 1990-02-16 | 1992-06-15 | Om Lab Sa | |
| US6592876B1 (en) * | 1993-04-20 | 2003-07-15 | Uab Research Foundation | Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products |
| EP0885965A3 (en) * | 1997-06-20 | 2000-01-12 | Smithkline Beecham Corporation | Histidine kinase polypeptides |
| US6858706B2 (en) * | 1998-04-07 | 2005-02-22 | St. Jude Children's Research Hospital | Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof |
| ES2343492T3 (es) * | 1998-04-07 | 2010-08-02 | Medimmune, Llc | Derivados de proteinas neumococicas de union a colina para vacunas. |
| US20010016200A1 (en) * | 1998-04-23 | 2001-08-23 | Briles David E. | Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor |
| EP1073450A4 (en) * | 1998-04-23 | 2003-04-23 | Uab Research Foundation | PNEUMOCOCCAL SURFACE PROTEIN C (PSPC), EPITOPIC REGIONS, SELECTION OF CORRESPONDING STRES AND USES |
| GB9816337D0 (en) * | 1998-07-27 | 1998-09-23 | Cortecs Uk Ltd | Proteins |
| KR20020027311A (ko) | 1999-05-07 | 2002-04-13 | 제넨테크, 인크. | Ｂ 세포 표면 마커에 결합하는 길항물질을 이용한자가면역 질환의 치료 |
| MXPA01012721A (es) * | 1999-06-10 | 2004-10-14 | Uab Research Foundation | Vacuna de combinacion de proteinas de superficie neumococcicas. |
| AU2001287645A1 (en) * | 2000-07-20 | 2002-02-05 | Hansa Medical Ab | Fh-binding protein of streptococcus pneumiae |
| EP1301602A2 (en) | 2000-07-20 | 2003-04-16 | Hansa Medical AB | Fh-binding protein of streptococcus pneumoniae |
| US6957392B2 (en) * | 2002-01-16 | 2005-10-18 | Laszlo Systems, Inc. | Interface engine providing a continuous user interface |
| DE10258924A1 (de) * | 2002-12-17 | 2004-07-08 | Eberhard-Karls-Universität Tübingen Universitätsklinikum | Mit die Adhäsion von biologischem Material vermittelnden Substanzen beschichtete Vorrichtung |
| EP1919934A2 (en) * | 2005-05-13 | 2008-05-14 | Novartis Vaccines and Diagnostics, Inc. | Serum resistance factors of gram positive bacteria |
| EP1843375B1 (de) * | 2006-04-05 | 2011-07-06 | ABB Technology AG | Elektromagnetischer Aktuator, insbesondere für einen Mittelspannungsschalter |
| DE102010001914A1 (de) * | 2010-02-15 | 2011-08-18 | Robert Bosch GmbH, 70469 | Lenkvorrichtung für ein Kraftfahrzeug |
| WO2012072769A1 (en) * | 2010-12-01 | 2012-06-07 | Novartis Ag | Pneumococcal rrgb epitopes and clade combinations |
| WO2012087925A1 (en) * | 2010-12-20 | 2012-06-28 | The Trustees Of The University Of Pennsylvania | Factor h binding peptides and uses thereof |
| WO2012134975A1 (en) * | 2011-03-28 | 2012-10-04 | St. Jude Children's Research Hospital | Methods and compositions employing immunogenic fusion proteins |
| JP6057265B2 (ja) * | 2013-08-21 | 2017-01-11 | 国立大学法人大阪大学 | 標的物質とリガンドとの結合親和性を測定するための方法、ならびに該方法に使用するための試薬助剤およびキット |
-
2013
- 2013-10-14 GB GBGB1318170.6A patent/GB201318170D0/en not_active Ceased
-
2014
- 2014-10-13 EP EP14789350.7A patent/EP3057979B1/en active Active
- 2014-10-13 AU AU2014335925A patent/AU2014335925B2/en active Active
- 2014-10-13 CN CN202110888795.4A patent/CN114028538A/zh active Pending
- 2014-10-13 BR BR112016008055A patent/BR112016008055A2/pt not_active Application Discontinuation
- 2014-10-13 JP JP2016522745A patent/JP6691042B2/ja active Active
- 2014-10-13 CA CA2925663A patent/CA2925663A1/en active Pending
- 2014-10-13 US US15/029,399 patent/US10035827B2/en active Active
- 2014-10-13 EP EP20176131.9A patent/EP3757115B1/en active Active
- 2014-10-13 CN CN202110888802.0A patent/CN114031676A/zh active Pending
- 2014-10-13 ES ES20176131T patent/ES3037618T3/es active Active
- 2014-10-13 CN CN201480056203.0A patent/CN105764918B/zh active Active
- 2014-10-13 DK DK14789350.7T patent/DK3057979T3/da active
- 2014-10-13 ES ES14789350T patent/ES2800599T3/es active Active
- 2014-10-13 WO PCT/GB2014/053072 patent/WO2015055991A1/en not_active Ceased
-
2018
- 2018-07-06 US US16/028,740 patent/US10774116B2/en active Active
-
2019
- 2019-03-15 AU AU2019201829A patent/AU2019201829B2/en active Active
- 2019-10-28 JP JP2019195276A patent/JP6987825B2/ja active Active
-
2020
- 2020-08-17 US US16/995,344 patent/US20210017239A1/en not_active Abandoned
- 2020-11-25 AU AU2020277188A patent/AU2020277188B2/en active Active
-
2021
- 2021-09-24 US US17/483,920 patent/US20220009974A1/en not_active Abandoned
- 2021-12-01 JP JP2021195598A patent/JP7320585B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020039342A5 (enExample) | ||
| US4442133A (en) | Antibiotic bonding of vascular prostheses and other implants | |
| US5811151A (en) | Method of modifying the surface of a medical device | |
| JP2005523116A (ja) | 生物学的に活性なポリマーケーシングを有する埋込み型医療装置 | |
| US20090053278A1 (en) | Anti-microbial compositions and devices and methods of using the same | |
| US5415938A (en) | Biocompatability of solid surfaces | |
| Mendez et al. | Mechanoresponsive drug release from a flexible, tissue‐adherent, hybrid hydrogel actuator | |
| JP2007523633A5 (enExample) | ||
| JP2010523264A5 (enExample) | ||
| JP2004267791A5 (enExample) | ||
| JPH09164212A (ja) | 強化された感染抵抗を有する筋肉内刺激リード | |
| JP2004523537A5 (enExample) | ||
| BR0315130A (pt) | Composições para terapia celular, terapeuticamente efetivas e de encapsulamento de material biológico, respectivos método e uso | |
| CY1108765T1 (el) | ΑΓΩΓΗ ME ΑΝΤΙΣΩΜΑΤΑ ANTI-ErbB2 | |
| BRPI1104008A2 (pt) | adiÇço de porosidade microscàpica À superfÍcie de uma micromola para ser usada em implante mÉdico | |
| JP2007521937A (ja) | タンパク質ポリマーおよび多機能スペーサーを含む創傷被覆材 | |
| Kwant et al. | Sticky science: Using complex coacervate adhesives for biomedical applications | |
| CN102477172B (zh) | 壳聚糖-肝素纳米颗粒以及用该纳米颗粒处理的去细胞基质的生物材料 | |
| CN109821076A (zh) | 一种抗凝抗感染的多功能涂层的制备方法及抗凝抗感染的多功能材料 | |
| CN110290817B (zh) | 转谷氨酰胺酶处理的产品 | |
| WO2002058728A3 (en) | Polypeptides capable of binding to cd64 and comprising one or more heterologous t cell epitopes, and their uses | |
| CN105418953A (zh) | 一种在医用聚氨酯材料表面修饰磷酸胆碱的方法 | |
| CN114522278A (zh) | 一种长效抗凝血涂层及其制备方法 | |
| RU2302880C2 (ru) | Новый специфический механизм ингибирования адгезии тромбоцитов к коллагену | |
| Brzeziński et al. | Evaluation of local tissue reaction after the application of a 3D printed novel holdfast device for left atrial appendage exclusion |